Decoy Therapeutics Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Decoy Therapeutics Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2022.

  • Decoy Therapeutics Inc. showed a decrease of -100.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
  • This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2023.
  • XBRL data for this metric is available from 2016 to 2022 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2016 to 2022), Decoy Therapeutics Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
  • Historical annual values: Fiscal year 2022: $0.00 | Fiscal year 2021: $1.84 million | Fiscal year 2020: $5.23 million | Fiscal year 2019: $3.47 million | Fiscal year 2018: $1.95 million | Fiscal year 2017: $1.27 million | Fiscal year 2016: $1.01 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: